(2019) Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways. International immunopharmacology. pp. 321-327. ISSN 1878-1705 (Electronic) 1567-5769 (Linking)
Full text not available from this repository.
Abstract
The objective of the present study was to compare the host's immune responses between unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis (ACL) treated by meglumine antimoniate. A case-control study was carried out in an endemic focus in Iran. Blood samples were taken from patients and peripheral blood mononuclear cells (PBMCs) were isolated. Two wells were considered for each isolate of unresponsive and responsive patients; one was exposed to L. tropica (Lt-stimulated cells) and the other remained non-exposed (non-stimulated cells). After 24h of incubation, whole RNA was extracted from each sample. Real-time quantitative PCR was carried out to confirm the differences in expression levels of IL-12 P40, IFN-gamma, IL-1beta, IL-4 and IL-10 among isolates. Data were analyzed and P<0.05 was considered to be statistically significant. In our study, Lt-stimulated cells and non-stimulated cells in unresponsive groups demonstrated significantly lower expression levels of IL-1beta, IL-12 P40 and IFN-gamma genes and higher expression levels of IL-4 and IL-10 genes, compared to Lt-stimulated cells and non-stimulated cells in responsive groups. There was a negative correlation between IL-12 P40 with IL-10 and IL-1beta with IL-10 in ACL Lt-stimulated cells in unresponsive group, while a positive correlation between IL-12 P40 with IL-1beta and IL-12 P40 with IFN-gamma in ACL Lt-stimulated cells in responsive group. Probably, different immune responses caused by various factors play a major role in the pathogenesis and development of unresponsiveness in ACL patients. The profile and timing of cytokine production correlated well with the treatment outcome of Leishmania infection.
Item Type: | Article |
---|---|
Keywords: | Antiprotozoal Agents/*therapeutic use Case-Control Studies Cells, Cultured Cytokines/genetics/metabolism Endemic Diseases Female Gene Expression Regulation Humans Inflammation Mediators/metabolism Iran Leishmania tropica/*physiology Leishmaniasis, Cutaneous/*drug therapy Leukocytes, Mononuclear/*drug effects/physiology Male Meglumine Antimoniate/*therapeutic use Th1 Cells/immunology Treatment Outcome Anthroponotic cutaneous leishmaniasis Case-control study Immune response Th1 and Th2 Unresponsive patients |
Divisions: | |
Page Range: | pp. 321-327 |
Journal or Publication Title: | International immunopharmacology |
Journal Index: | Pubmed |
Volume: | 69 |
Identification Number: | https://doi.org/10.1016/j.intimp.2019.02.008 |
ISSN: | 1878-1705 (Electronic) 1567-5769 (Linking) |
Depositing User: | مهندس مهدی شریفی |
URI: | http://eprints.mubam.ac.ir/id/eprint/698 |
Actions (login required)
![]() |
View Item |